For those who have plateaued on semaglutide or want maximal weight loss potential, switching between the two medications is possible under provider guidance, and IVIM dose conversion protocols make the transition smoother

Monitoring considerations include: Regular assessment of gastrointestinal tolerability and hydration status Evaluation of any changes in MS symptoms, with low threshold for neurological consultation Glucose monitoring in diabetic patients, with adjustment of other antihyperglycemic agents as needed Periodic assessment of weight loss progress and nutritional adequacy Monitoring for signs of pancreatitis (severe abdominal pain) or gallbladder disease For Wegovy patients, monitoring for depression or suicidal thoughts Patient counseling should address realistic expectations regarding weight loss (typically 15% of body weight over 68 weeks with the 2.4 mg dose plus lifestyle intervention, with less at earlier timepoints), the chronic nature of therapy, and the importance of lifestyle modifications

7 The evolving public perception of obesity and food addiction As the success of GLP-1RAs in treating overweight and obesity rises, it prompts reflection on how these pharmacological advances could reshape both public and professional perspectives
Alemany S, Avella-Garca C, Liew Z, Garca-Esteban R, Inoue K, Cadman T, Lpez-Vicente M, Gonzlez L, Riao Galn I, Andiarena A, Casas M, Margetaki K, Strandberg-Larsen K, Lawlor DA, El Marroun H, Tiemeier H, Iiguez C, Tardn A, Santa-Marina L, Jlvez J, Porta D, Chatzi L, Sunyer J
Watch This Video About Neumi NutriSwish The Neumi Breakthrough The Power of Nano Glutathione (2:09 minutes) About Neumi Skin For Brighter, Healthier Skin Weve solved a problem thats been around since the first person said skin care, and thats absorption
David Ludwig, nutrition and obesity expert at Harvard University, called for a more balanced approach, according to the Associated Press (AP)